Clinical trial
Study on The Oral Immune Tolerance of CMPA Infants Using Amino Acid Formula
NCT03769051 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study on The Oral Immune Tolerance of CMPA Infants Using Amino Acid Formula
- Lead sponsor
- Peking University Third Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 20, 2015
- Completion date
- April 30, 2019
- Enrollment
- 200 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
cow's milk protein allergy